Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
glufosfamide (2 trials)
Carcinoma (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Small Cell (Phase 2)
Hypersensitivity (Phase 2)
Lung Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Trials (2 total)
Trial APIs (1 total)